How to serve the customer and still be truthful: Methodological characteristics of applied research

Science and Public Policy

Volumn 33, Issue 6, 2006, Pages 435-444

  Adam, Matthias ^a   Carrier, Martin ^b   Wilholt, Torsten ^b  

^a Bielefeld University ^*  (Germany)

^b BIELEFELD UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

RESEARCH AND DEVELOPMENT; TECHNOLOGICAL DEVELOPMENT; THEORETICAL STUDY;

EID: 33749185149     PISSN: 03023427     EISSN: None     Source Type: Journal    
DOI: 10.3152/147154306781778849     Document Type: Article

References (36)

1. Adam, Matthias 2005. Integrating research and development: the emergence of rational drug design in the pharmaceutical industry. Studies in History and Philosophy of Biological and Biomedical Sciences, 36, 513-537.
2. Bacon, Francis 1620. Neues Organon. Hamburg: Meiner (1999).
3. Banhart, J, H Ebert and A Vernes 1997. Applicability of the two-current model for systems with strongly spin-dependent disorder. Physical Review, B 56(16), 10165-10171.
4. Barthélémy, A, A Fert and F Petroff 1999. Giant magnetoresistance in magnetic multilayers. In Handbook of Magnetic Materials, XII, ed. K H J Buschow, pp. 1-96. Amsterdam: Elsevier.
5. Byers, L D and R Wolfenden 1973. Binding of the by-product analog benzylsuccinic acid by carboxypeptidase A. Biochemistry, 12, 2070-2078.
6. Carrier, Martin 2004a. Knowledge and control: on the bearing of epistemic values in applied science. In Science, Values and Objectivity, eds. P Machamer and G Wolters, pp. 275-293. Pittsburgh: University of Pittsburgh Press.
7. Carrier, Martin 2004b. Knowledge gain and practical use: models in pure and applied research. In Laws and Models in Science, ed. D Gillies, pp. 1-17. London: King's College Publications.
8. Carrier, Martin 2006a. The challenge of practice: Einstein, technological development and conceptual innovation. In Special Relativity: Will it Survive the Next 100 Years? ed. C Lämmerzahl. Heidelberg: Springer.
9. Carrier, Martin 2006b. Science in the grip of the economy: on the epistemic impact of the commercialization of research. In Science and the Social: Knowledge, Epistemic Demands, and Social Values, eds. M Carrier et al Forthcoming.
10. Carrier, Martin 2006c. Wissenschaft im Dienst am Kunden: Zum Verhältnis von Verwertungsdruck und Erkenntniserfolg. In Philosophie im interdisziplinären Dialog, ed. B Falkenburg. Paderborn: Mentis. Forthcoming.
11. Cartwright, Nancy 1996. Fundamentalism versus the patchwork of laws. In The Philosophy of Science, ed. D Papineau, pp. 314-326. Oxford: Oxford University Press.
12. Coehoorn, Reinder 2003. Giant magnetoresistance and magnetic interactions in exchange-biased spin valves. In Handbook of Magnetic Materials, XV, ed. K H J Buschow, pp. 1-197. Amsterdam: Elsevier.
13. Cushman, David W et al 1977. Design of potent competitive inhibitors of angiotensin-converting enzyme. carboxyalkanoyl and mercaptoalkanoyl amino acids. Biochemistry, 16, 5484-5491.
14. Cushman, D W and M A Ondetti 1991. History of the design of captopril and related inhibitors of angiotensin converting enzyme. Hypertension, 17, 589-592.
15. Folkerts, W and J C S Kools 1998. Experimental study of the validity of simple design rules for the biasing of spin-valve-type GMR heads. Sensors and Actuators A, 64, 237-240.
16. Funtowicz, S O and J R Ravetz 1993. The emergence of post-normal science. In Science, Politics, and Morality, Scientific Uncertainty and Decision Making, ed. R von Schomberg, pp. 85-123. Dordrecht: Kluwer.
17. Gambardella, Alfonso 1995. Science and Innovation. The US Pharmaceutical Industry during the 1980s. Cambridge: Cambridge University Press.
18. Gibbons, Michael et al 1994. The New Production of Knowledge. The Dynamics of Science and Research in Contemporary Sciences. London: Sage.
19. Gijs, M A M and G E W Bauer 1997. Perpendicular giant magnetoresistance of magnetic multilayers. Advances in Physics, 46(3/4), 285-445.
20. Grünberg, Peter 2001. Layered magnetic structures: history, highlights, applications. Physics Today, 54, 31-37.
21. Hack, Lothar 2001. "Ich habe da eine Theorie" oder: Neue Fokussierung von Kontext/en und Kompetenz/en. In Neue Formen der Wissenserzeugung, ed. G Bender, pp. 23-56. Frankfurt: Campus.
22. Kuhn, Peter et al 2002. The genesis of high-throughput structure based drug discovery using protein crystallography. Current Opinion in Chemical Biology, 6, 704-710.
23. Maxwell, R A and S B Eckhardt 1990. Drug Discovery. A Casebook and Analysis. Clifton: Humana.
24. Morrison, Margaret 1999. Models as autonomous agents. In Models as Mediators: Perspectives on Natural and Social Sciences, eds. M S Morgan and M Morrison, pp. 38-65. Cambridge: Cambridge University Press.
25. Nicholls, M Gary et al 1994. Blockade of the renin-angiotensin system. Journal of Hypertension, 12, Suppl. 10, S95-S103.
26. Nowotny, H, P Scott and M Gibbons 2001. Re-Thinking Science: Knowledge and the Public in an Age of Uncertainty. Cambridge: Polity.
27. Parkin, Stuart P P 1991. Systematic variation of the strength and oscillation period of indirect magnetic exchange coupling through the 3d, 4d, and 5d transition metals. Physical Review Letters, 67(25), 3598-3601.
28. Parkin, Stuart P P 2002. Applications of magnetic nanostructures. In Spin Dependent Transport in Magnetic Nanostructures (Advances in Condensed Matter Science 3), eds. S Maekawa and T Shinjo, pp. 237-271. London: Taylor & Francis.
29. Quiocho, F A and W N Lipscomb 1971. Carboxypeptidase A: a protein and an enzyme. Advances in Protein Chemistry, 25, 1-78.
30. Rammert, Werner 2004. Two Styles of Knowing and Knowledge Regimes: Between "Explication" and "Exploration" under Conditions of "Functional Specialization" or "Fragmental Distribution". Technical University Technology Studies Working Papers TUTS-WP-3-2004. Berlin: Institut für Soziologie TU Berlin.
31. Smith, C G and J R Vane 2003. The discovery of captopril. FASEB Journal, 17, 788-789.
32. Stokes, Donald E 1997. Pasteur's Quadrant Basic Science and Technological Innovation. Washington DC: Brookings.
33. Timmermans, Pieter B et al 1995. Discovery of Iosartan, the first angiotensin II receptor antagonist. Journal of Human Hypertension, 9, Suppl. 5, S3-S18.
34. Weingart, Peter 1997. From "finalization" to "mode 2": old wine in new bottles? Social Science Information, 36, 591-613.
35. Wilholt, Torsten 2006. Design rules: industrial research and epistemic merit. Philosophy of Science. Forthcoming.
36. Winsberg, Eric 2003. Simulated experiments: methodology for a virtual world. Philosophy of Science, 70, 105-125.